🎉 The third round of DG-GT #PaperOfTheQuarterAwards 2025! 🎉 We are delighted to award… … Pascal Wang and the Buchholz Lab (TU Dresden) … Maria Silvia Roman Azcona and the Mussolino Lab (University of Freiburg) … Lasse Neukirch and Silke Uhrig-Schmidt (DKFZ) Congratulations to all! 👏 #DGGTeV

Visit our booth in the Registration Hall & test your skills in our daily Pipetting Game 🧪 Beat our board member Prof. Anja Ehrhardt! Our game ist open: 📅 Every day ⏰ 10:30 AM – 05:30 PM Each day’s top pipetter will get a prize at the end of the day from our Microbes plushies🦠 #ESGCT2025 #DGGZTeV

We are proud to see young German researchers presenting their exciting work at ESGCT: 🎤 Presentations: Akshatha Shivaraj Kerstin Geiger 🖼️ Posters: Stylianos Michalakis Fabian John Muhammed Burak Demircan Maren Soldierer Alexandre Trubert Melissa Whitehead #DGGTeV #GeneTherapy #ESGCT2025

Congratulations! The #DGGTeV awards J. Geilenkeuser and N. Armbrust at @tum.de and @www.helmholtz-munich.de​ for their work on Engineered Nucleocytosolic Vehicles for Loading Programmable Editors (ENVLPE) to deliver gene editors into target cells. more here: https://www.dg-gt.de/paper-of-the-quarter

The #DGGTeV is delighted to present Ana-Maria Nitulescu at @bihatcharite.bsky.social​ with one of our #PaperoftheQuarter #Awards #2025Q2 for her work to improve KI efficiency for non-viral CAR T cell production: https://www.dg-gt.de/paper-of-the-quarter #DGGTeV#PaperoftheQuarter#Awards#2025Q2s://www.dg-gt.de/paper-of-the-quarter

Congratulations! The #DGGTeV proudly presents Elham Adabi at @pei.de the #PaperoftheQuarterAward #25Q1 2/3 for her outstanding work focusing on the enhancement of CAR T cell manufacturing by modulating the MAPK/ERK pathway. details here: https://www.dg-gt.de/paper-of-the-quarter#DGGTeV#PaperoftheQuarterAward#25Q1#PoQ #GeneTherapy

The #DGGTeV is delighted to present A.C. Dragon from the Institute of Transfusion Medicine and Transplant Engineering at MHH with a #PoQ Award #2025Q1 3/3 for her work in transplantation to deplete alloreactive B cells using drug-resistant CAR T cells. https://www.dg-gt.de/paper-of-the-quarter#DGGTeV

The first round of the #DGGTeV #PaperoftheQuarterAwards 2025 is here: We are delighted to award Franziska Baatz at MHH for her work to investigate and target BCL11B in CAR-engineered lymphoid progenitors. Read more here: https://www.dg-gt.de/paper-of-the-quarter#DGGTeV#PaperoftheQuarterAwards#PoQ #2025Q1 1/3

Highlighst of the 2025 ThemeDay! Last but not least of our awardees: Congratulations to Zi Xi Dai from @tudresden.bsky.social receiving the best poster award (2/2) at the #DGGTeV #Themeday2025 for presenting his work developing Designer-Recombinase induced Gene Replacement (DRiGR) #Recombinase

Last chance to submit your recent #GeneTherapy manuscript for the #DGGTeV Paper of the quarter award! #PoQ #2025Q1 Deadline is the 10th of April. Submission: https://www.dg-gt.de/poq-submission

This morning the DGGTeV and the VfA are hosting a joint parliamentary breakfast to discuss the future of #GeneTherapy and #CellTherapy in #Germany with representatives of the German parliament and give stakeholders from academia and industry an opportunity to share insights and voice opinions

Highlights of the 2025 #DGGTeV #Themeday: Congratulations! Ina Luksch @tum.de#DGGTeV#Themedayis awarded for the best oral presentation at the DGGTeV Themeday presenting her work on AAV-mediated #GeneTherapy in a porcine model of #DuchenneMuscularDystrophy

Highlighst of the 2025 ThemeDay: Congratulations to Masako Kaufmann @uni-freiburg.de for the best poster at the #DGGTeV #Themeday2025 for her work on #BaseEditing #offtarget detection via universal CAST-Seq

Thank you for a wonderful #ThemeDay25 in Dresden and see you at the DGGT/ESGCT Springschool in Postdam, the 32. ESGCT Congress this fall in Sevilla, or next year at the joint #DGGTeV and 33. #ESGCT Congress 2026 in Hamburg https://www.esgct.eu/upcoming-events

The #DGGTeV is invested into the future of #GeneTherapy #Research in Germany Therefore, local schools were invited today to join Session 5 discussing the ethics of #GenomeEditing with Karla Axel and Klaus Tanner from @uniheidelberg.bsky.social Details here: https://bit.ly/3FlRPLM#DGGTeV#GeneTherapy#Research#GenomeEditing#DGGTeVTeV #ThemeDay

Session 4 focuses on novel gene editing technologies and their applications with scientists from @uni-freiburg.de @fraunhofer.bsky.social Seamless Therapeutics and @upf.edu presenting their work. Details here: https://www.dg-gt.de/event-programme #GeneTherapy #DGGTeV #ThemeDay25

Starting the 2. day of the #DGGTeV #GenomeEditing #ThemeDay with a highlight: the Keynote Lecture of Kathleen Collins from @ucberkeleyofficial.bsky.social#DGGTeV#GenomeEditing#ThemeDay retroelement proteins for #GeneTherapy

Science never sleeps - but sometimes it is better discussed over a few drinks. PhD Students, PIs and Industry gathering to promote #GeneTherapy in a relaxed atmosphere. Time for networking and discussions, for building collaborations and lasting friendships at the #DGGTeV #DinnerEvent at Pulverturm

The first day of the 2025 #DGGTeV #GenomeEditing #ThemeDay is concluded with a tour of the German Hygiene Museum Dresden to revisit past breakthroughs and find inspiration in the dedication to science and health. See you tomorrow for the Keynote of Kathleen Collins @ucberkeleyofficial.bsky.social

Session 3 is all about the clinical applications @uniregensburg.bsky.social, MHH, Uni Tübingen, @goetheuni.bsky.social, @tum.de present current challenges and novel solutions. #DGGTeV

Session 2 focuses on #DELIVERY How to get the tools you need to the correct compartment at the correct time efficiently? Scientist from @unileipzig.bsky.social Pantherna, MHH, AkribionT. and Charité provide insights. More details here: https://bit.ly/41FywEG#DELIVERY

Session 1 today focuses on CRISPR-Screens featuring talks from @uniheidelberg.bsky.social, @ethzurich.bsky.social, @tum.de, Uni WittenHerdecke and @cytiva.bsky.social Check the online programme for more here: https://www.dg-gt.de/currentmeeting #GeneTherapy #DGGTeV #GenomeEditing

A warm welcome from local organizers @buchholzlab.bsky.social and our President Zoltan Ivicz to the 2025 Theme Day of the #DGGTeV on Genome Editing at the German Hygiene Museum in Dresden We are looking forward to 2 days packed with great talks, interesting posters, and lively discussions!

Great chance to enhance your research and clinical skills❗ Apply now for a @dkfz.bsky.social CLINICIAN SCIENTIST FELLOWSHIP 👉 https://linke.to/DKFZClinicianScientistFellowships2025 @gustaveroussy.fr@nkinl.bsky.social@ki.se @nct-heidelberg.bsky.social@crukcamcentre.bsky.social@vhio.bsky.social

#RareStories and #RarePersons : Each Person is rare and valuable - regardless if the disease is rare #Rarediseaseday #GeneTherapy #DGGZTeV

#RareStories and #RarePersons : Each Person is rare and valuable - regardless if the disease is rare #Rarediseaseday #GeneTherapy #DGGZTeV

#RareStories and #RarePersons : Each Person is rare and valuable - regardless if the disease is rare #Rarediseaseday #GeneTherapy #DGGZTeV

Please support #RareDiseaseDay #lightupforrare #lightup4rare

#RareStories and #RarePersons : Each Person is rare and valuable - regardless if the disease is rare too #Rarediseaseday #GeneTherapy #DGGZTeV

#RareFact 9 Patients with #rare#rarecancers have a suboptimal 5-year survival, partially because they need #rare individual treatments. #Rarediseaseday #GeneTherapy #DGGZTeV

#RareFact 8 Even generally common diseases like cancer can be highly specific in individual form and treatment. #GeneTherapy #Rarediseaseday #DGGZTeV

#RareFact 7 Place of birth, gender and skin color should not decide the availability of treatment options. We are working towards research and treatment being equally accessible to everyone. #GeneTherapy #Rarediseaseday #DGGZTeV

#RareFact 6 Many #rarediseases start during childhood - the younger the patient the more time to gain #GeneTherapy #Rarediseaseday #DGGZTeV

#Rarefact 5 Most rare diseases have a genetic cause - brilliant #scientists around the world and in #Germany are developing #GeneTherapy approaches to treat or cure them. #Rarediseaseday #DGGZTeV

#RareFact 4 There are many #rarediseases . There is a lot to do. #rarediseaseday #GeneTherapy #DGGZTeV

#RareFact 3 #Rarediseaseday An entire country full of patients affected by rare diseases surely would try to build a medical system and the necessary research to accommodate their needs - we should aim to do the same #GeneTherapy #DGGZTeV

#RareFact 2 Because it is #rarediseaseday, today we are sharing facts and information on rare diseases On all other days we #research ways to treat patients with #rarediseases #communicate our findings and build networks for #cooperation and the future of #GeneTherapy #Aware#rarefor #rare #DGGZTeV

Today is #rarediseaseday There are so many cases of individually #rare diseases it wouldn't be rare or surprising at all to meet an affected person - But #care and #therapy for these patients is rarely available. The first step is #education and #awareness. Let's start today https://bit.ly/3Dnw11A

Welcome to the bluesky account of the German Society for Gene and Cell Therapy #DGGZTeV Just in time for the #rarediseaseday the DGGZT is finally part of the bluesky family. We are here to #connect #communicate and spread #awareness Follow us for more #Rare #GeneTherapy #Germany #Science